Insights

Specialty Pipeline ImprimisRx operates in specialty pharmaceuticals with a growing portfolio of proprietary sterile and topical formulations for ophthalmology, dermatology and wound care, including advanced compounded products. This signals opportunities to engage clinics and hospital systems needing customized, cost-effective treatments and formulary-ready options.

Telemedicine Advantage A telemedicine partnership with Doxy.me enables remote ophthalmology care; use this to offer integrated pharmacy services, remote patient support and easy drug access. Target telehealth networks, multi-site groups, and Doxy.me users for co-marketing and bundled care programs.

Affordable Alternatives A stated focus on accessible pricing, including cheaper alternatives to brand meds like Restasis. Position as a cost-effective option for eye care and dermatology clinics, with opportunity for volume procurement, contract pricing and patient assistance programs.

Growth and Scale Industry recognition for fast growth suggests operational capability to support expanding clinic networks and multi-site partnerships. Use this credibility to pursue enterprise accounts, distributors and group purchasing organizations seeking reliable specialty suppliers.

Custom Compounding The ability to deliver custom sterile and topical medicines gives sales teams a differentiator for practices needing patient-specific formulations. Target ophthalmology, dermatology, wound care centers, offer formulary support, clinician education and patient-adherence programs.

ImprimisRx® - A Harrow Company Tech Stack

ImprimisRx® - A Harrow Company uses 8 technology products and services including Unpkg, Amazon S3, OneTrust, and more. Explore ImprimisRx® - A Harrow Company's tech stack below.

  • Unpkg
    Content Delivery Network
  • Amazon S3
    Content Delivery Network
  • OneTrust
    Cookie Compliance
  • Twemoji
    Font Scripts
  • yepnope.js
    Javascript Frameworks
  • Salesforce Marketing Cloud Account Engagement
    Marketing Automation
  • Microsoft Office
    Office Suites
  • Slack
    Software Framework

Media & News

ImprimisRx® - A Harrow Company's Email Address Formats

ImprimisRx® - A Harrow Company uses at least 2 format(s):
ImprimisRx® - A Harrow Company Email FormatsExamplePercentage
FLast@imprimisrx.comJDoe@imprimisrx.com
93%
Last@imprimisrx.comDoe@imprimisrx.com
5%
First.Last@imprimisrx.comJohn.Doe@imprimisrx.com
2%
FLast@imprimispharma.comJDoe@imprimispharma.com
95%
Last@imprimispharma.comDoe@imprimispharma.com
4%
First@imprimispharma.comJohn@imprimispharma.com
1%

Frequently Asked Questions

Where is ImprimisRx® - A Harrow Company's headquarters located?

Minus sign iconPlus sign icon
ImprimisRx® - A Harrow Company's main headquarters is located at 1000 Aviara Parkway Suite 220 Carlsbad, California 92011 United States. The company has employees across 2 continents, including North AmericaEurope.

What is ImprimisRx® - A Harrow Company's official website and social media links?

Minus sign iconPlus sign icon
ImprimisRx® - A Harrow Company's official website is imprimisrx.com and has social profiles on LinkedInCrunchbase.

What is ImprimisRx® - A Harrow Company's NAICS code?

Minus sign iconPlus sign icon
ImprimisRx® - A Harrow Company's NAICS code is 621 - Ambulatory Health Care Services.

How many employees does ImprimisRx® - A Harrow Company have currently?

Minus sign iconPlus sign icon
As of June 2026, ImprimisRx® - A Harrow Company has approximately 133 employees across 2 continents, including North AmericaEurope. Key team members include Founder Of Imprimisrx, Llc: M. L. B.Senior Vice President Operations: C. E.Director Of Compounding: F. A.. Explore ImprimisRx® - A Harrow Company's employee directory with LeadIQ.

What industry does ImprimisRx® - A Harrow Company belong to?

Minus sign iconPlus sign icon
ImprimisRx® - A Harrow Company operates in the Medical Practices industry.

What technology does ImprimisRx® - A Harrow Company use?

Minus sign iconPlus sign icon
ImprimisRx® - A Harrow Company's tech stack includes UnpkgAmazon S3OneTrustTwemojiyepnope.jsSalesforce Marketing Cloud Account EngagementMicrosoft OfficeSlack.

What is ImprimisRx® - A Harrow Company's email format?

Minus sign iconPlus sign icon
ImprimisRx® - A Harrow Company's email format typically follows the pattern of FLast@imprimisrx.com. Find more ImprimisRx® - A Harrow Company email formats with LeadIQ.

How much funding has ImprimisRx® - A Harrow Company raised to date?

Minus sign iconPlus sign icon
As of June 2026, ImprimisRx® - A Harrow Company has raised $253K in funding. The last funding round occurred on Dec 20, 2022 for $253K.

When was ImprimisRx® - A Harrow Company founded?

Minus sign iconPlus sign icon
ImprimisRx® - A Harrow Company was founded in 2012.
ImprimisRx® - A Harrow Company logo

ImprimisRx® - A Harrow Company

Medical PracticesCalifornia, United States51-200 Employees

ImprimisRx is a specialty pharmaceutical company focused on developing and commercializing proprietary sterile and topical drug formulations. Based in the San Diego area, with a Carlsbad, California address, it operates as a mid-sized organization in the medical practices sector and emphasizes a distinctive business approach aimed at delivering customizable medicines to physicians and patients at accessible prices. The firm seeks to build long-term relationships with its customers by emphasizing responsiveness and value, supported by a collaborative internal culture.

Its customer base includes physicians and patients who benefit from novel formulations, and the company highlights ongoing product development as part of its growth. Recent launches such as DuoClear in 2023 and Fortisite in 2022 illustrate its continuing product innovation, alongside a focus on attracting and retaining talent to sustain its operations and growth.

Section iconCompany Overview

Headquarters
1000 Aviara Parkway Suite 220 Carlsbad, California 92011 United States
NAICS Code
621 - Ambulatory Health Care Services
Founded
2012
Employees
51-200

Section iconFunding & Financials

  • $253K

    ImprimisRx® - A Harrow Company has raised a total of $253K of funding over 1 rounds. Their latest funding round was raised on Dec 20, 2022 in the amount of $253K.

  • $25M$50M

    ImprimisRx® - A Harrow Company's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $253K

    ImprimisRx® - A Harrow Company has raised a total of $253K of funding over 1 rounds. Their latest funding round was raised on Dec 20, 2022 in the amount of $253K.

  • $25M$50M

    ImprimisRx® - A Harrow Company's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.